CIK: 0001388325 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value ($000): $1,353,230 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BN | BROOKFIELD CORP | 3,880,230 | $121,335 | 9.0% | $22.16 | 0.0% | CL A LTD VT SH | 11271J107 |
| ASML | ASML HOLDING N V | 197,760 | $116,413 | 8.6% | $654.82 | — | N Y REGISTRY SHS | N07059210 |
| CRM | SALESFORCE.COM, INC. | 530,500 | $107,575 | 7.9% | $193.03 | +10.6% | COM | 79466L302 |
| CORT | CORCEPT THERAPEUTICS INC | 3,377,768 | $92,044 | 6.8% | $23.02 | +25.8% | COM | 218352102 |
| — | LANZATECH GLOBAL INC | 15,814,845 | $73,855 | 5.5% | $3.88 | — | COM | 51655R101 |
| CABO | CABLE ONE INC | 118,403 | $72,894 | 5.4% | $987.67 | -36.5% | COM | 12685J105 |
| TSM | TAIWAN SEMICONDUCTOR MFG LTD | 710,780 | $61,767 | 4.6% | $96.28 | — | SPONSORED ADS | 874039100 |
| IRON | DISC MEDICINE, INC. | 1,090,772 | $51,244 | 3.8% | $49.79 | +0.5% | COM | 254604101 |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,500,000 | $47,400 | 3.5% | $12.27 | +123.2% | COM | 604749101 |
| BABA | ALIBABA GROUP HLDG LTD | 500,827 | $43,442 | 3.2% | $165.09 | — | SPONSORED ADS | 01609W102 |
| PCVX | VAXCYTE INC | 845,000 | $43,078 | 3.2% | $26.47 | +86.4% | COM | 92243G108 |
| ACLX | ARCELLX, INC. | 1,075,000 | $38,571 | 2.9% | $17.96 | +92.0% | COMMON STOCK | 03940C100 |
| AAPL | APPLE INC | 221,460 | $37,916 | 2.8% | $90.57 | +100.2% | COM | 037833100 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 400,000 | $35,392 | 2.6% | $83.79 | +6.2% | COM | 09061G101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,071,703 | $34,791 | 2.6% | $30.65 | -77.8% | COM | 28036F105 |
| — | SEAGEN INC. | 159,986 | $33,941 | 2.5% | $141.01 | — | COM | 81181C104 |
| INSM | INSMED INC | 1,339,304 | $33,817 | 2.5% | $23.10 | -1.0% | COM PAR $.01 | 457669307 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,100,000 | $32,714 | 2.4% | $19.36 | +6.4% | COM | 22663K107 |
| PHVS | PHARVARIS N V | 1,329,325 | $27,743 | 2.1% | $11.67 | +58.0% | COM | N69605108 |
| — | BLUEPRINT MEDICINES CORP | 525,000 | $26,366 | 1.9% | $59.75 | — | COM | 09627Y109 |
| FOLD | AMICUS THERAPEUTICS INC | 2,095,900 | $25,486 | 1.9% | $13.12 | -1.7% | COM | 03152W109 |
| — | RENEO PHARMACEUTICALS INC | 3,330,377 | $25,344 | 1.9% | $9.33 | — | COM | 75974E103 |
| — | CYMABAY THERAPEUTICS INC | 1,566,521 | $23,357 | 1.7% | $10.95 | — | COM | 23257D103 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 118,383 | $20,966 | 1.5% | $160.04 | +19.4% | COM | 02043Q107 |
| BAM | BROOKFIELD ASSET MANAGMT LTD | 627,207 | $20,911 | 1.5% | $31.11 | 0.0% | CL A LMT VTG SHS | 113004105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,001,000 | $20,510 | 1.5% | $28.64 | -36.5% | COM | 77313F106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,200,000 | $15,276 | 1.1% | $18.73 | -10.7% | COM | 35104E100 |
| — | SPRUCE BIOSCIENCES INC | 6,722,336 | $15,192 | 1.1% | $17.05 | — | COM | 85209E109 |
| INSP | INSPIRE MED SYS INC | 60,000 | $11,906 | 0.9% | $206.06 | +22.4% | COM | 457730109 |
| IOBT | IO BIOTECH INC | 5,747,067 | $8,103 | 0.6% | $6.26 | -71.9% | COM | 449778109 |
| — | RALLYBIO CORP | 2,187,999 | $7,374 | 0.5% | $6.73 | — | COM | 75120L100 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,126,915 | $5,184 | 0.4% | $8.47 | -28.2% | COM | 00288U106 |
| — | SILK RD MED INC | 333,884 | $5,005 | 0.4% | $41.80 | — | COM | 82710M100 |
| TMCI | TREACE MED CONCEPTS INC | 360,000 | $4,720 | 0.3% | $25.28 | -27.6% | COM | 89455T109 |
| — | LAVA THERAPEUTICS NV | 2,400,000 | $3,528 | 0.3% | $15.19 | — | SHS | N51517105 |
| MQ | MARQETA INC | 441,558 | $2,641 | 0.2% | $22.37 | -74.6% | CLASS A COM | 57142B104 |
| — | CYTEIR THERAPEUTICS INC | 676,379 | $1,921 | 0.1% | $21.40 | — | COM | 23284P103 |
| — | GALECTO INC | 2,497,791 | $1,798 | 0.1% | $12.51 | — | COM | 36322Q107 |
| — | KINNATE BIOPHARMA INC | 815,707 | $1,142 | 0.1% | $25.36 | — | COM | 49705R105 |
| SPRO | SPERO THERAPEUTICS INC | 468,902 | $567 | 0.0% | $11.41 | -87.9% | COM | 84833T103 |